Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailability is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high expression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis and vasodilation; thus, a protective role of insulin on high D-glucose-alterations in endothelial function is likely. Vascular reactivity to U46619 (thromboxane A 2 mimetic) and calcitonin gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose. hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein kinases (p42/44 mapk ), protein kinase B/Akt (Akt) expression and activity were determined by western blotting and qRT-PCR, tetrahydrobiopterin (BH 4 ) level was determined by HPLC, and L-arginine transport (0-1000 μmol/L) was measured in response to 5-25 mmol/L D-glucose (0-36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs •-/NADPH oxidase pathways. These findings are of interest for better understanding vascular dysfunction in states of foetal insulin resistance and hyperglycaemia.
Introduction
Hyperglycaemia and diabetes mellitus are pathological conditions associated with foetal endothelial dysfunction [1] [2] [3] [4] and type 2 diabetes mellitus (T2DM) [5] or cardiovascular disease (CVD) [6, 7] in adulthood. CVD in patients with diabetes mellitus is associated with the generation of reactive oxygen species (ROS) [8] caused by chronic hyperglycaemia [3] and insulin resistance [9] . Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) activity and endothelial nitric oxide (NO) synthase (eNOS) uncoupling leads to vascular ROS generation [10] , of which superoxide anion (O 2
•-) reduces NO bioavailability, generating peroxynitrite (ONOO -) and resulting in altered vascular endothelial function [11] . NO is synthesised by eNOS from the cationic amino acid L-arginine, which is taken up from the extracellular space by the human cationic amino acid transporter 1 (hCAT-1), a member of the cationic amino acid transporter (CATs) family [11] , in human umbilical vein endothelial cells (HUVECs) [12] . Thus, NO bioavailability depends on eNOS activity and hCAT-1 expression and activity [13] , as well as ROS levels [11] , in this cell type.
Elevated extracellular D-glucose increases hCAT-1-mediated L-arginine transport and NO synthesis (the 'L-arginine/NO pathway') [14, 15] as well as intracellular ROS generation [16, 17] , leading to endothelial dysfunction [2] . Insulin causes human umbilical vein endotheliumdependent dilation and increases hCAT-1 expression caused by elevated SLC7A1 (encoding hCAT-1) transcriptional activity [12, 14, 18] and NO synthesis [12] . Additionally, insulin reverses the gestational diabetes mellitus (GDM) or high D-glucose-associated stimulation of the L-arginine/NO pathway in HUVECs [11] . We hypothesise that insulin has a beneficial antioxidant capacity that reverses the high D-glucose-associated increase in ROS generation. We studied the effect of high extracellular D-glucose on insulin modulation of the L-arginine/NO and NADPH oxidase/O 2
•-pathways in fetoplacental vascular reactivity. The results suggest that D-glucose-increased oxidative stress and vascular dysfunction are attenuated by insulin. Thus, insulin likely acts as an antioxidant under conditions of hyperglycaemia, leading to protection of the fetoplacental endothelium in diseases associated with endothelial dysfunction such as GDM.
Methods

Ethics statement
This investigation conforms to the principles outlined in the Declaration of Helsinki and has received approval from the Ethics Committee of the Faculty of Medicine of the Pontificia
The maximal velocity (V max ) and apparent Michaelis-Menten constant (K m ) of saturable transport were calculated as described [12, 14, 18] .
Western blotting
Total protein was obtained from the confluent cells, washed twice with ice-cold PBS and harvested in 100 μL of lysis buffer (63.7 mmol/L Tris/HCl (pH 6.8), 10% glycerol, 2% sodium dodecyl sulphate, 1 mmol/L sodium orthovanadate, 50 mg/mL leupeptin, 5% 2-mercaptoethanol) as described [12] . The cells were sonicated (six cycles, 5 seconds, 100 W, 4°C), and total protein was separated by centrifugation (12,000 rpm, 15 minutes, 4°C). The proteins (50 μg) were separated by polyacrylamide gel (8-10%) electrophoresis and transferred to Immobilon-P polyvinylidene difluoride membranes (BioRad Laboratories, Hertfordshire, UK). The proteins were then probed with primary monoclonal mouse anti-hCAT-1 (1:1500, 12 hours, 4°C) (Sigma-Aldrich, St. Louis, MO, USA), primary polyclonal goat anti-total and phosphorylated mitogen-activated 42 and 44 kDa protein kinases (p42/44 mapk , 1:1000) or protein kinase B/Akt (Akt, 1:1000) (Cell Signalling, Danvers, MA, USA) or monoclonal mouse anti-ß-actin (1:2000, 1 hour, room temperature) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. The membranes were rinsed in Tris-buffered saline with Tween (TBS-T) and incubated (1 hour) in TBS-T/0.2% bovine serum albumin (BSA) containing secondary horseradish peroxidase-conjugated goat anti-mouse (AbCam, Cambridge, MA, USA) or anti-goat (Santa Cruz Biotechnology) antibodies. Proteins were detected by enhanced chemiluminescence (film exposure time was 2 min) in a ChemiDoc-It 510 Imagen System (UVP, LCC Upland, CA, USA) and quantified by densitometry as described [12] .
Immunofluorescence and confocal laser scanning microscopy
The HUVECs were grown on microscope cover slips (10 6 Vectashield mounting medium and stained with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA, USA). The samples were analysed under an Olympus IX81 microscope with a disk scanning unit (DSU) spinning disk confocal system (Olympus, Tokyo, Japan). The images were obtained with a Hamamatsu ORCA-R2 camera (Hamamatsu Photonics, Hamamatsu, Japan) controlled by the Olympus XcellenceR software using a Plan Apo N 60x 1.42 NA objective. Each sample was examined through successive 0.2 μm optical slices along the z axis, and the obtained images were post-processed by applying a Wiener filter deconvolution provided by the Olympus software.
Total RNA isolation and reverse transcription
Total RNA was isolated using the Chomczynski method as previously described [12] . The RNA quality and integrity were ensured by gel visualisation and spectrophotometric analysis (OD 260/280 ), quantified at 260 nm and precipitated to obtain 4 μg/μL RNA. Aliquots (1 μg) of the total RNA were reverse transcribed into cDNA as described [14, 18, 19] .
Quantitative RT-PCR
The experiments were performed using a LightCycler rapid thermal cycler (Roche Diagnostics, Lewes, UK) in a reaction mixture containing 0.5 μmol/L primers, dNTPs, Taq DNA polymerase and reaction buffer provided in QuantiTectSYBR Green PCR Master Mix (QIAGEN, Crawley, UK) as described [8, 18, 19] . Hot Start Taq DNA polymerase was activated (15 minutes, 95°C), and the assays included 95°C denaturation (15 seconds), annealing (20 seconds) at 54°C (hCAT-1 and 28S), and extension (10 seconds) at 72°C (hCAT-1 and 28S). The product melting temperatures were 79.1°C (hCAT-1) and 86.7°C (28S). The following oligonucleotide primers were used: hCAT-1 (sense) 5'-GAGTTAGATCCAGCAGACCA-3', hCAT-1 (anti-sense) 5'-TGTTCACAATTAGCCCAGAG-3', 28S (sense) 5'-TTGAAAATCCGGGGGAGAG-3', 28S (anti-sense) 5'-ACATTGTTCCAACATGCCAG-3'. The number of copies of 28S rRNA was not significantly altered (P > 0.05, n = 4) in any experimental conditions used in this study.
Actinomycin D effect on hCAT-1 mRNA
Total RNA and protein were isolated from the HUVECs cultured in PCM containing 5 or 25 mmol/L D-glucose (24 hours) in the absence or presence (8 hours) of 1.5 μmol/L actinomycin D (transcription inhibitor) [20] and/or 1 nmol/L insulin. The hCAT-1 mRNA and 28S rRNA were quantified by real-time RT-PCR.
hCAT-1 promoter cloning
The upstream sequences -1606 and -650 bp from the transcription start codon of the SLC7A1 gene (GenBank: AL596114) were PCR-amplified and cloned into the pGL3-basic reporter system to generate the pGL3-hCAT1 -1606 and pGL3-hCAT1 -650 reporter constructs as described [12, 18, 19] .
Transient transfection
Sub-confluent (60-80%) HUVECs primary cultures were resuspended in serum-free M199. Aliquots of the cell suspension (0.5 mL, 3.2 x10 6 cells/mL) were mixed with 10 μg of the pGL3-hCAT1 -1606 or pGL3-hCAT1 -650 constructs, pGL3-Basic (empty pGL3 vector), pGL3-Control (Simian Virus 40 promoter (SV40) pGL3 vector), and the internal transfection control vector, pRL-TK expressing Renilla luciferase (Promega) [19, 20] . After electroporation (300 Volts, 700 μF, 5-10 milliseconds) (Gene Pulser II System, BioRad, CA, USA), the cells were cultured (49 hours) in M199 containing 2% FCS. The transfection efficiency was estimated by transfection of the pEGFP-N3 vector (Clontech, Mountain View, CA, USA), and the fluorescent cells were counted under an inverted fluorescent microscope (Leica DMIL; Wetzlar, Germany) [19, 20] .
Luciferase assay
The electroporated cells were lysed in 200 μL of passive lysis buffer (Promega), and firefly and Renilla luciferase activity were measured using the Dual-Luciferase Reporter Assay System (Promega) in a Sirius luminometer (Berthold Detection System; Oak Ridge, TN, USA) [19, 20] .
Intracellular ROS and NO
Intracellular ROS and NO levels were determined using the fluorescent dyes 5-(and-6)- 
Tetrahydrobiopterin (BH 4 ) determination by HPLC
The level of BH 4 was determined by an acid-base oxidation method followed by fluorometric detection by high performance liquid chromatography (HPLC). The total biopterins level (BH 4 + dihydrobiopterin (BH 2 ) + biopterins) were determined by acid oxidation and BH 2 + biopterins levels by basic oxidation, following a modification of the method described by Fukushima & Nixon [22] . Confluent HUVECs in 100 mm diameter culture plates in 5 or 25 mmol/L glucose in the absence or presence (24 hours) of 1 nmol/L insulin, 100 μmol/L apocynin, 100 μmol/L Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (Mn(III) TMPyP), or 1 mmol/L tempol were collected in cold PBS (4°C). Cells were then centrifuged (1,000 g, 2 minutes, 4°C) and lysed in 200 μL of biopterins lysis buffer ((mmol/L): 50 Tris-HCl (pH 7.4), 2 dithiothreitol (DTT), 1 ethylenediamine tetraacetic acid (EDTA)). Cells were then sonicated (tree cycles, 10 seconds, 100W, 4°C) and centrifuged (13,500 g, 20 minutes, 4°C). Proteins were quantified in 20 μL of the supernatants by a modified Lowry method (Bio-Rad DC protein assay, BioRad Laboratories) as described [12] . Proteins contained in 180 μL of supernatant were precipitated by mixing with 20 μL of 1.5 M HClO 4 :2 M H 3 PO 4 = 1:1 (v/v) by strong vortex (5 seconds), allowing 30 minutes (4°C) incubation and further centrifugation (13,500 g, 5 minutes, 4°C). Aliquots of 90 μL of the protein-free supernatant were used for total biopterins determination by acid oxidation with 10 μL of iodine/KI acid solution (1% iodine in a 2% KI solution prepared in 1 M HCl). For BH 2 + biopterins determination an alkali oxidation was performed by mixing 10 μL of 1 M NaOH with 80 μL of protein-free supernatant, followed by addition of 10 μL of iodine/KI alkali solution (1% iodine in a 2% KI solution prepared in 1 M NaOH). Samples for total biopterins and BH 2 + biopterins determination were incubated at 23°C for 1 hour in darkness. After this incubation period iodine in the samples was reduced by adding 5 μL of fresh ascorbic acid (20 mg/mL). Samples for BH 2 + biopterins determination were acidified by mixing with 20 μL of 1 M H 3 PO 4 . All samples (i.e., acid and alkali oxidation) were centrifuged (13,500 g, 5 minutes, 23°C), passed through a Millex syringe-driven filter unit (Millipore Corporation, Billerica, MA, USA) and loaded in an analytical column (C 18 : 4.6 mm x 150 mm) (HiQsil, KYA Tech, Japan) coupled to a HPLC system (PU2089S, Jasco, Japan). The analytical column was washed by passing through ultrapure water (Milli-Q, Millipore Corporation) (pH 7.3, 23°C, 20 minutes) and further washed with methanol (>99%, 20 minutes).
The column was then equilibrated with the mobile phase (5% methanol, 95% water) for 40 minutes with a flow rate of 1 mL/minute. Fluorescence was monitored at excitation and emission wavelengths of 350 and 450 nm, respectively, by using the fluorescent detector (FP 2020 Plus, Jasco, Japan) of the HPLC system. Biopterins were quantified against the standard curve 0-100 nmol/L L-biopterin (Sigma-Aldrich). The chromatograms were obtained and analysed by using the software ChromPass 1.7 (ChromPass Chromatography Data System, Jasco, Japan). BH 4 was determined as the difference between the areas under the curve in chromatograms for total biopterins and BH 2 + biopterin. Values for BH 4 level are given in pmol/μg protein.
•-was quantified using lucigenin (Sigma-Aldrich) [23] . 
Umbilical vein reactivity
Ring segments (2-4 mm length) from human umbilical veins were mounted in a myograph (610M Multiwire Myograph System, Danish Myo Technology A/S, Denmark) for isometric force measurements with the optimal diameter adjusted from the maximal active response to 90 mmol/L KCl, as described [12] . The vessels were incubated (24 hours, 37°C) with 5 or 25 mmol/L D-glucose, 5 mmol/L D-glucose + 20 mmol/L D-mannitol, 100 μmol/L apocynin, 1 nmol/L insulin and/or 1 mmol/L tempol. After this incubation period, the response to increasing concentrations of U46619 (0.1-1000 nmol/L, 5 minutes) (thromboxane A 2 analogue) [12, 24] or calcitonin gene related peptide (CGRP, 0.001-100 nmol/L, 5 minutes) [12] (SigmaAldrich) was assayed.
Statistical analysis
The values are the mean ± S.E.M. for different cell cultures (with 3-4 replicates) from an equal number of placentas (n = 33). The data reported in this study describe a normal standard distribution. The comparisons between two or more groups were performed using Student's unpaired t-test and analysis of variance (ANOVA), respectively. If the ANOVA demonstrated a significant interaction between the variables, post hoc analyses were performed by the multiplecomparison Bonferroni correction test. The GraphPad Instat 3.0b and GraphPad Prism 6.0f (GraphPad Software, Inc., San Diego, CA, USA) statistical software packages were used for the data analysis. P<0.05 was considered significant.
Results
High D-glucose increases L-arginine uptake and hCAT-1 expression
High D-glucose increased L-arginine transport in a concentration-and time-dependent manner ( Fig 1A) . The D-glucose effect was biphasic, with an initial increase from 2 hours of (Fig 1B) . The pp SE 50 and sp SE 50 values of hCAT-1 mRNA expression were lower than the corresponding values for hCAT-1 protein abundance (Table 1) .
Insulin blocks D-glucose-increased hCAT-1 activity and expression
We previously reported that insulin increases the V max of L-arginine transport, without altering the apparent K m , in a concentration-dependent manner in HUVECs cultured in 5 mmol/L Dglucose [12] . The high D-glucose effect was reflected in a higher V max /K m , with a maximal transport increase at 1 nmol/L insulin [12] . Insulin blocked the increase in L-arginine transport caused by high D-glucose in a concentration-dependent manner by decreasing the V max (Fig 2A) and V max /K m (Table 1) values of transport, with a half-maximal inhibitory concentration (IC 50 ) for an insulin effect of 0.11 ± 0.007 nmol/L (Fig 2B) .
Insulin restored the increase in hCAT-1 protein abundance (Fig 3A) , hCAT-1 mRNA expression ( Fig 3B) and fluorescence (Fig 3C) . In addition, high D-glucose and insulin increased these parameters in cells in 5 mmol/L D-glucose. Actinomycin D blocked the effect of high D-glucose on hCAT-1 mRNA expression (Fig 3D) . Insulin blocks D-glucose-increased ROS and NO synthesis D-Glucose increased ROS formation (SC 50 = 9.9 ± 0.5 mmol/L), an effect abolished by apocynin and insulin (Fig 4A) . High D-glucose also increased O 2 •-generation, which was abolished by apocynin, insulin and/or tempol (Fig 4B) . High D-glucose and insulin increased the NO level in cells in 5 mmol/L D-glucose; however, insulin but not apocynin or tempol blocked the high D-glucose-mediated increase in the NO level (Fig 4C) .
SOD mimetics block D-glucose-reduced BH 4 level
HUVECs exposed to high D-glucose show lower BH 4 level compared with cells in 5 mmol/L D-glucose, an effect unaltered by insulin or apocynin (Fig 4D) . However, the SOD mimetics tempol and Mn(III)TMPyP increased the BH 4 (Fig 5A) and Akt (Fig 5B) phosphorylation, but tempol did not alter the phosphorylation of these molecules under this experimental condition. High D-glucose increased p42/44 mapk , but not Akt phosphorylation, which was reduced by insulin or tempol.
Insulin Blocks D-Glucose-Increased ROS 
Role of NADPH oxidase on hCAT-1 expression
Apocynin blocked the increase in hCAT-1 protein abundance (Fig 5C) , hCAT-1 mRNA expression (Fig 5D) , and SLC7A1 promoter activity caused by high D-glucose in cells transfected with the pGL3-hCAT1 -650 construct (Fig 5E) . However, the increase in these parameters caused by insulin in cells in 5 mmol/L D-glucose was unaltered by this inhibitor. (Fig 6A) . The SC 50 for the U46619 effect in high D-glucose (24.5 ± 0.6 nmol/L) was lower (P < 0.05) than that in 5 mmol/L D-glucose (62.3 ± 0.9 nmol/L). Insulin, apocynin and tempol blocked the U46619-increased contraction in high D-glucose (Fig 6B) . Umbilical vein rings in high D-glucose show reduced maximal dilation in response to CGRP compared with vein rings in 5 mmol/L D-glucose (Fig 6C) . The half-effective concentration (EC 50 ) for the CGRP vasodilation was similar in both experimental conditions (9.7 ± 0.2 and 9.6 ± 0.2 nmol/L for 5 and 25 mmol/L D-glucose, respectively). Insulin, but not apocynin or tempol increased vein rings dilation in 5 mmol/L D-glucose; however, these molecules reversed the high D-glucose-decreased vein rings dilation (Fig 6D) . occurring earlier than hCAT-1 protein abundance (78 ± 7 minutes). No reports are available that address the potential half-life of the hCAT-1 protein and hCAT-1 mRNA in human endothelial cells [11] . The CAT-1 mRNA half-life was 90-250 minutes in the rat hepatoma FTO2B cell line [26] and approximately 75 minutes in the stably transfected rat glioma C6 cell line [27] . In addition, CAT-1 mRNA turnover in response to amino acid deprivation increased between 6-12 hours. Thus, hCAT-1 mRNA turnover would be approximately 12 hours in response to high D-glucose, with a half-life of 1-2 hours in HUVECs in 5 mmol/L D-glucose in the absence of insulin. After challenge with high D-glucose, the hCAT-1 mRNA turnover kinetics could be extended to approximately 6-12 hour cycles. Insulin increases L-arginine transport and NO synthesis involving protein kinase B (PKB)/ Akt in HAECs [25] . Incubation of HAECs with 25 mmol/L D-glucose increased L-arginine transport, which is blocked by 1 nmol/L insulin. High D-glucose-increased hCAT-1 protein abundance, and activity in HUVECs was also blocked by insulin; however, the insulin effect was observed at a lower concentration (~10-fold) in HUVECs than in HAECs, with IC 50 close to insulinemia in human umbilical vein (~0.041 nmol/L) [28] and whole umbilical cord (~0.025 nmol/L) [29, 30] . Thus, HUVECs are highly sensitive to insulin compared with HAECs. Insulin also restored the high D-glucose-mediated increase in V max /K m , suggesting a lower number of membrane transporters rather than reduced affinity of a fixed number of transporters [11, 18] . Indeed, insulin restored hCAT-1 protein abundance and the plasma membrane/cytosol distribution. Temporality in changes mediated by high D-glucose in hCAT-1 protein abundance and activity are similar; thus, increased transport caused by high D-glucose could result from higher hCAT-1 protein abundance, preferentially localised at the plasma membrane in HUVECs. High D-glucose-associated changes in hCAT-1 expression could result from transcriptional and/or post-transcriptional modulation by insulin. In fact, the insulin effect requires transcriptional regulatory factors acting at the -650 bp fragment of the promoter region of SLC7A1. Specific protein 1 (Sp1) mediates insulin effects in several cell types, similar to other TATA-less promoters [11, 31, 32] , including increased SLC7A1 transcriptional activity in HUVECs [12] . SLC7A1 exhibits at least four Sp1 consensus sequences between -177 and -105 bp from its translation start point in HUVECs [11, 12] , making it likely that insulin-restored SLC7A1 promoter activity results from reduced Sp1 activity. However, other transcription factor(s) that reduce SLC7A1 transcriptional activity, such as the C/EBP homologous protein 10 (CHOP) as reported in C6 rat glioma cells [33] , may be involved in mediating insulin effects.
NADPH oxidase generates ROS in HUVECs exposed to hyperglycemia [18] . We showed that high D-glucose increases ROS generation with a SC 50 value of approximately 11 mmol/L, which is similar to the stimulatory effect by high D-glucose on L-arginine transport (SC 50 of 13 mmol/L). Thus, the high D-glucose-mediated increase in ROS generation could lead to increased L-arginine transport in HUVECs. Because ROS generation was blocked by apocynin, high D-glucose activation of NAPDH oxidase is feasible, agreeing with findings in human umbilical artery endothelium exposed to 30 mmol/L D-glucose [34] and in EAhy926 cells (immortalised endothelial cell line) exposed to 35 mmol/L D-glucose [35] . Apocynin blocked the high D-glucose-mediated increase in ROS and O 2
•-generation in similar proportions (~69 and 83%, respectively), suggesting that O 2 •-is the main form of NADPH oxidase-generated ROS (~82% High D-glucose caused comparable increases in NO and ROS generation; thus, these phenomena are linked in HUVECs, agreeing with a report on this cell type when it was incubated with 75 mmol/L D-glucose [39] . The high D-glucose-mediated increase in NO synthesis is NADPH oxidase-independent, as apocynin was ineffective. However, because insulin blocked the D-glucose effect on NO synthesis and ROS generation, an alternative mechanism for the response to this hormone in HUVECs is likely. Thus, insulin could be equally active in preventing O 2
• 
•-generation by reducing the eNOS dimer/monomer ratio (i.e., uncoupled eNOS) and NO synthesis in EA.hy926 cells exposed to 35 mmol/L D-glucose [35] , (c) restoration of eNOS dimerization and function by BH 4 administration in diabetic rats [36] and (d) restoration by apocynin of the diabetes mellitus-increased eNOS-derived O 2
•-in mice [41] . Taking Increases in hCAT-1 protein abundance, hCAT-1 mRNA expression and SLC7A1 promoter activity by high D-glucose, but not insulin, were blocked by apocynin, suggesting a NADPH oxidase-dependent mechanism. It has been reported that eNOS activity is associated with higher hCAT-1-mediated L-arginine transport in EA.hy926 cells [13] . Because insulin blocked the increase in V max /K m for L-arginine transport but reduced the high-D-glucose-mediated increase in the NO level by~63%, the high D-glucose effect was partially dependent (~25-30%) on L-arginine transport in HUVECs. In addition, lower hCAT-1 protein abundance compared with reduced V max /K m could be mainly responsible (~75%) for the insulin-mediated reversal of NO synthesis. Our findings also show that insulin reduced hCAT-1 protein abundance at the plasma membrane at high D-glucose concentrations. Because insulin increased hCAT-1 protein abundance in membrane fractions in HUVECs in 5 mmol/L D-glucose [12] and caused a general increase in its cellular distribution in this cell type, reduced hCAT-1 protein abundance at the plasma membrane in cells challenged with high D-glucose could be caused by insulin. These findings support the possibility that not only a reduction in the total protein abundance but also potential hCAT-1 redistribution results from incubation with high D-glucose and insulin. The opposite response to insulin regarding hCAT-1 activity and expression in HUVECs in 5 mmol/L versus 25 mmol/L D-glucose is a finding that is similar to the differential response to this hormone reported for eNOS expression and activity as well as for the human equilibrative nucleoside transporter 1 (hENT1) expression and activity in HUVECs from normal pregnancies compared with GDM pregnancies [38] . The mechanisms behind these opposite effects of insulin involve activation of A 1 and A 2A adenosine receptors leading to modulation of the biological effect of insulin in HUVECs from normal pregnancies [18] , GDM pregnancies [38] , and in preeclampsia [43] . These mechanisms were not evaluated in this study; however, it is suggested that insulin could use an intracellular metabolic machinery to modulate expression of SLC29A7 and hCAT-1 protein that is different in HUVECs in a normal or high D-glucose environment, as reported in GDM [44] .
Umbilical vein contraction was caused by the thromboxane A 2 mimetic U46619, as reported in human chorionic plate arteries [24] . The U46619 maximal contraction in high D-glucose conditions was higher (~1. HUVECs exposure to high D-glucose increases L-arginine transport (Fig 7) , likely resulting from higher hCAT-1 expression and protein abundance in the plasma membrane. This mechanism could be an adaptive response of HUVECs to higher ROS and O 2
•-generation from high D-glucose-activated NADPH oxidase. In parallel, high D-glucose increased NO synthesis, which was independent of NADPH oxidase activation. Insulin reversed the high D-glucosemediated alterations in L-arginine transport involving the modulation of SLC7A1 gene expression, leading to altered umbilical vein reactivity. Modulation of hCAT-1 expression and activity is key to maintaining umbilical vein tone and endothelial function. Most diseases of pregnancy progress with oxidative stress leading to altered placental vascular reactivity [11] . Thus, management of potential pro-oxidative stress conditions is necessary to prevent fetoplacental endothelial dysfunction, thus ensuring an adequate supply of nutrients to the growing foetus. 
